GlassScriptPhysician profile
David P Dobesh
NPI 1083838890
$46,536.36
in general payments reported to CMS, 2019-2025
45 companies · $1,173 in 2025
The $1,173 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,459 · 2021: $5,872 · 2022: $6,774 · 2023: $6,013 · 2024: $10K · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,625 · Food and Beverage: $4,353 · Travel and Lodging: $3,155 · Entertainment: $64.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,625.00 |
| Food and Beverage | $4,353.01 |
| Travel and Lodging | $3,155.01 |
| Entertainment | $64.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34,015.50 | 2019-2025 | Watchman Flx, Watchman Access System, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $4,885.57 | 2019-2025 | Mitraclip, Cardiomems, Amplatzer Amulet |
| Medical Device Business Services, INC. | $2,406.87 | 2019 | |
| Edwards Lifesciences Corporation | $1,987.52 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia, Hemosphere |
| Medtronic, INC. | $375.94 | 2021-2025 | Corevalve Evolut R, Linq II, Aurora Ev-Icd Mri Surescan |
| Novartis Pharmaceuticals Corporation | $235.37 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.82 | 2019-2024 | Lifevest |
| Biosense Webster, INC. | $200.82 | 2019-2021 | |
| Novo Nordisk INC | $167.06 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Cvrx, INC. | $156.90 | 2021 | |
| Cardiva Medical, INC. | $144.16 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Ensoetm, Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $143.18 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $125.00 | 2019 | |
| Pfizer INC. | $118.31 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $87.13 | 2021-2023 | Eliquis, Camzyos |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dobesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.